Screener
The Cooper Companies, Inc. COO Coopersurgical Segment — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Cooper Companies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026.
- Filed
- Jun 5, 2026, 4:47 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-041305
| Periods Ended April 30, / (In millions) | Three Months / 2026 | Three Months / 2025 | Six Months / 2026 | Six Months / 2025 |
|---|---|---|---|---|
| Toric and multifocal | $364.9 | $328.4 | $716.1 | $647.8 |
| Sphere, other | 358.6 | 341.2 | 702.5 | 667.9 |
| Total CooperVision net sales | $723.5 | $669.6 | $1,418.6 | $1,315.7 |
| CooperSurgical net sales by category: | ||||
| Office and surgical | $214.2 | $205.8 | $416.6 | $404.7 |
| Fertility | 143.8 | 126.9 | 270.4 | 246.6 |
| Total CooperSurgical net sales | 358.0 | 332.7 | 687.0 | 651.3 |
| Total net sales | $1,081.5 | $1,002.3 | $2,105.6 | $1,967.0 |
Item 1. Unaudited Financial Statements
FAQ
- What is The Cooper Companies, Inc.'s coopersurgical segment — net sales?
- The Cooper Companies, Inc. (COO) reported coopersurgical segment — net sales of $358M in Q1 2026.
- How has The Cooper Companies, Inc.'s coopersurgical segment — net sales changed year-over-year?
- The Cooper Companies, Inc.'s coopersurgical segment — net sales increased by 7.6% year-over-year, from $332.7M to $358M.
- What is the long-term trend for The Cooper Companies, Inc.'s coopersurgical segment — net sales?
- Over 4 years (2021 to 2025), The Cooper Companies, Inc.'s coopersurgical segment — net sales has grown at a 15.0% compound annual growth rate (CAGR), from $770.5M to $1.35B.
- What does coopersurgical segment — net sales mean?
- This metric represents the total revenue generated by the CooperSurgical business segment, which focuses on medical devices and fertility solutions. It reflects the market demand for the company's specialized surgical products and reproductive health technologies. This figure is a primary indicator of the segment's commercial success and its contribution to the overall corporate top-line growth.
Ask your AI about The Cooper Companies, Inc.'s coopersurgical segment — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude